BNP Paribas Aktienanleihe FRE 26..../ DE000PG217T6 /
1/23/2025 9:30:17 PM | Chg.+0.520 | Bid9:58:05 PM | Ask9:58:05 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
103.970EUR | +0.50% | 104.000 Bid Size: 20,000 |
104.100 Ask Size: 20,000 |
FRESENIUS SE+CO.KGAA... | 32.00 EUR | 6/26/2025 | Call |
GlobeNewswire
4/24/2024
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
4/23/2024
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
2/23/2024
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
9/4/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
8/31/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil